Aandelen in “Productie van analytische laboratoriuminstrumenten”

Aandeel Datum Koers Evolutie
vlag Waters Corp. 12/03 283,320 USD
-4,78% 		-4,78%

Nieuws over “Productie van analytische laboratoriuminstrumenten”

12/03 · Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities · Persbericht

12/03 · Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities · Persbericht

9/03 · Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed · Persbericht

5/03 · Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering · Persbericht

27/02 · Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida · Persbericht

25/02 · Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics · Persbericht

24/02 · Illumina launches TruPath Genome, setting a new standard in genomic insight · Persbericht

23/02 · Waters Corporation to Present at the TD Cowen Health Care Conference · Persbericht

23/02 · Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility · Persbericht

23/02 · Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 · Persbericht

19/02 · Tradr Debuts Leveraged ETFs on Centrus Energy, CleanSpark and Coherent · Persbericht

17/02 · Illumina To Webcast Upcoming Investor Conference · Persbericht

17/02 · Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage · Persbericht

11/02 · Avantor® Reports Fourth Quarter and Full Year 2025 Results · Persbericht

9/02 · BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation · Persbericht

9/02 · Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses · Persbericht

9/02 · Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results · Persbericht

5/02 · Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 · Persbericht

4/02 · Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026 · Persbericht

3/02 · Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally · Persbericht

30/01 · Illumina completes acquisition of SomaLogic · Persbericht

Mijn selecties